Godshalk Welsh Capital Management’s Quest Diagnostics DGX Stock Holding History

Godshalk Welsh Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$642K	Sell	3,275 -25	-0.8%	-$4.86K	0.37%	78
2025 Q4	$573K	Hold	3,300	–	–	0.33%	83
2025 Q3	$629K	Hold	3,300	–	–	0.36%	79
2025 Q2	$593K	Sell	3,300 -100	-3%	-$17.4K	0.37%	82
2025 Q1	$575K	Hold	3,400	–	–	0.38%	78
2024 Q4	$513K	Hold	3,400	–	–	0.33%	82
2024 Q3	$528K	Hold	3,400	–	–	0.33%	84
2024 Q2	$465K	Sell	3,400 -200	-6%	-$27.4K	0.31%	82
2024 Q1	$479K	Hold	3,600	–	–	0.32%	81
2023 Q4	$496K	Hold	3,600	–	–	0.36%	77
2023 Q3	$439K	Hold	3,600	–	–	0.33%	79
2023 Q2	$506K	Hold	3,600	–	–	0.35%	79
2023 Q1	$509K	Sell	3,600 -25	-0.7%	-$3.58K	0.36%	81
2022 Q4	$567K	Hold	3,625	–	–	0.41%	77
2022 Q3	$445K	Sell	3,625 -25	-0.7%	-$3.29K	0.33%	84
2022 Q2	$485K	Hold	3,650	–	–	0.35%	79
2022 Q1	$500K	Hold	3,650	–	–	0.31%	84
2021 Q4	$631K	Sell	3,650 -300	-8%	-$45.6K	0.36%	78
2021 Q3	$574K	Hold	3,950	–	–	0.36%	78
2021 Q2	$545K	Sell	3,950 -150	-4%	-$19.6K	0.34%	80
2021 Q1	$526K	Sell	4,100 -150	-4%	-$18.5K	0.37%	79
2020 Q4	$506K	Hold	4,250	–	–	0.37%	75
2020 Q3	$487K	Buy	4,250 +50	+1%	+$5.91K	0.41%	74
2020 Q2	$479K	Hold	4,200	–	–	0.45%	74
2020 Q1	$337K	Buy	4,200 +50	+1%	+$5.18K	0.37%	79
2019 Q4	$443K	Hold	4,150	–	–	0.37%	84
2019 Q3	$444K	Hold	4,150	–	–	0.39%	82
2019 Q2	$423K	Hold	4,150	–	–	0.39%	82
2019 Q1	$373K	Hold	4,150	–	–	0.36%	83
2018 Q4	$346K	Hold	4,150	–	–	0.39%	81
2018 Q3	$448K	Hold	4,150	–	–	0.44%	78
2018 Q2	$456K	Hold	4,150	–	–	0.48%	77
2018 Q1	$416K	Hold	4,150	–	–	0.45%	79
2017 Q4	$409K	Sell	4,150 -950	-19%	-$90.1K	0.41%	83
2017 Q3	$478K	Sell	5,100 -200	-4%	-$21.2K	0.48%	77
2017 Q2	$589K	Sell	5,300 -300	-5%	-$31.7K	0.58%	65
2017 Q1	$550K	Hold	5,600	–	–	0.54%	69
2016 Q4	$515K	Sell	5,600 -250	-4%	-$21.5K	0.53%	71
2016 Q3	$495K	Sell	5,850 -256	-4%	-$21.5K	0.51%	75
2016 Q2	$497K	Sell	6,106 -100	-2%	-$7.62K	0.52%	78
2016 Q1	$443K	Hold	6,206	–	–	0.46%	84
2015 Q4	$441K	Hold	6,206	–	–	0.46%	88
2015 Q3	$381K	Sell	6,206 -250	-4%	-$17.5K	0.42%	90
2015 Q2	$468K	Sell	6,456 -1,150	-15%	-$84.9K	0.48%	81
2015 Q1	$585K	Sell	7,606 -100	-1%	-$7.16K	0.6%	70
2014 Q4	$517K	Buy	+7,706	New	+$486K	0.47%	75

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Godshalk Welsh Capital Management's DGX Position: Q1 2026 in Review

Godshalk Welsh Capital Management reduced its Quest Diagnostics (DGX) stake by 0.76% in Q1 2026, selling an estimated $4.86K and leaving 3,275 shares worth $642K. The position accounts for 0.37% of the portfolio, ranked #78.

Godshalk Welsh Capital Management first reported a position in DGX in Q4 2014 and has held it in 46 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Godshalk Welsh Capital Management held 3,275 shares of Quest Diagnostics worth $642K as of Q1 2026.
Godshalk Welsh Capital Management sold 25 Quest Diagnostics shares in Q1 2026, an estimated $4.86K.
Quest Diagnostics made up 0.37% of Godshalk Welsh Capital Management's portfolio in Q1 2026, its #78 holding.
Godshalk Welsh Capital Management first reported a position in Quest Diagnostics in Q4 2014 and has held it in 46 quarters since.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Godshalk Welsh Capital Management's 13F filing for Q1 2026, filed 13 May 2026.